FDA names agency critic Prasad as top vaccine official By Dan Levine and Julie Steenhuysen Reuters May 6, 2025 U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has criticized FDA leadership and COVID-19 mandates, as director o…
Novo Nordisk's new obesity drug trial data disappoints again Mar 10, 2025 By Maggie Fick and Stine Jacobsen
US FDA approves Mirum Pharma's genetic disorder drug Feb 21, 2025 By Sriparna Roy and Kamal Choudhury
FDA approves SpringWorks' genetic disorder drug Reuters Feb 11, 2025 The Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare genetic disorder, whic…
FDA approves Supernus' drug-device combination for Parkinson's disease Reuters Feb 4, 2025 U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkins…
Cigna taking steps to lower out-of-pocket cost of prescription drugs Jan 29, 2025 (Reuters) -Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as it resp…
FDA puts clinical hold on Atara's trials for cancer cell therapy Reuters Jan 21, 2025 Atara Biotherapeutics on Tuesday said U.S. Food and Drug Administration has placed a clinical hold on its trials for cancer cell therapy.
Drug companies to raise prices on 250 medicine products By Michael Erman Reuters Dec 31, 2024 NEW YORK â€� Drug companies plan to raise U.S. prices on at least 250 branded medications, including Pfizer COVID-19 treatment Paxlovid, Bristol…
FDA approves BridgeBio's drug for rare heart condition Reuters Nov 22, 2024 U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said on Friday, making it t…
FDA extends review of Merus' gene-targeting cancer therapy Reuters Nov 5, 2024 U.S. Food and Drug Administration on Tuesday extended the review of Merus' gene-targeting cancer therapy to allow sufficient time to assess so…
